CN117679479A - A kind of traditional Chinese medicine compound preparation extract and preparation method - Google Patents
A kind of traditional Chinese medicine compound preparation extract and preparation method Download PDFInfo
- Publication number
- CN117679479A CN117679479A CN202311735336.8A CN202311735336A CN117679479A CN 117679479 A CN117679479 A CN 117679479A CN 202311735336 A CN202311735336 A CN 202311735336A CN 117679479 A CN117679479 A CN 117679479A
- Authority
- CN
- China
- Prior art keywords
- alcohol
- traditional chinese
- chinese medicine
- ethanol
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 74
- 239000000284 extract Substances 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 150000001875 compounds Chemical class 0.000 title claims abstract description 10
- 238000000605 extraction Methods 0.000 title description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 92
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000000203 mixture Substances 0.000 claims abstract description 32
- 241000245665 Taraxacum Species 0.000 claims abstract description 22
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 21
- 230000000694 effects Effects 0.000 claims abstract description 16
- 239000000287 crude extract Substances 0.000 claims abstract description 11
- 229940126680 traditional chinese medicines Drugs 0.000 claims abstract description 9
- 238000001035 drying Methods 0.000 claims abstract description 6
- 239000013049 sediment Substances 0.000 claims abstract description 6
- 238000001556 precipitation Methods 0.000 claims abstract description 5
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 6
- 240000009022 Smilax rotundifolia Species 0.000 claims abstract 5
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims abstract 5
- 241000050051 Chelone glabra Species 0.000 claims abstract 4
- 238000010438 heat treatment Methods 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 17
- 239000012141 concentrate Substances 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 15
- 239000002244 precipitate Substances 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 12
- 230000000844 anti-bacterial effect Effects 0.000 claims description 11
- 241000196324 Embryophyta Species 0.000 claims description 9
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 6
- 241000411851 herbal medicine Species 0.000 claims description 6
- 230000002421 anti-septic effect Effects 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 239000000725 suspension Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims 2
- 238000002156 mixing Methods 0.000 claims 2
- 239000000706 filtrate Substances 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 10
- 244000063299 Bacillus subtilis Species 0.000 abstract description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 abstract description 3
- 241000588724 Escherichia coli Species 0.000 abstract description 3
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 3
- 238000002474 experimental method Methods 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 238000001784 detoxification Methods 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 230000005764 inhibitory process Effects 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 230000007797 corrosion Effects 0.000 abstract 1
- 238000005260 corrosion Methods 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 241001570521 Lonicera periclymenum Species 0.000 description 16
- 241000362909 Smilax <beetle> Species 0.000 description 16
- 229930003935 flavonoid Natural products 0.000 description 13
- 150000002215 flavonoids Chemical class 0.000 description 13
- 235000017173 flavonoids Nutrition 0.000 description 13
- 239000000047 product Substances 0.000 description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 10
- 240000004534 Scutellaria baicalensis Species 0.000 description 9
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 241000207929 Scutellaria Species 0.000 description 6
- 241001122767 Theaceae Species 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 5
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 5
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 5
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 229940100243 oleanolic acid Drugs 0.000 description 5
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 5
- 150000003505 terpenes Chemical class 0.000 description 5
- 244000025254 Cannabis sativa Species 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- 235000007586 terpenes Nutrition 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 206010067125 Liver injury Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 231100000439 acute liver injury Toxicity 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 241001061264 Astragalus Species 0.000 description 2
- 244000167230 Lonicera japonica Species 0.000 description 2
- 235000017617 Lonicera japonica Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241001404789 Smilax glabra Species 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000006533 astragalus Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000003640 drug residue Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 238000011085 pressure filtration Methods 0.000 description 2
- 239000012088 reference solution Substances 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 241000605422 Asparagus asparagoides Species 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 235000010674 Prunella vulgaris Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000292546 Taraxacum mongolicum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000731 choleretic agent Substances 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229930182489 iridoid glycoside Natural products 0.000 description 1
- 150000008145 iridoid glycosides Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- JMZOMFYRADAWOG-UHFFFAOYSA-N methyl 7-methoxy-4-(7-methoxy-5-methoxycarbonyl-1,3-benzodioxol-4-yl)-1,3-benzodioxole-5-carboxylate Chemical compound COC(=O)C1=CC(OC)=C2OCOC2=C1C1=C2OCOC2=C(OC)C=C1C(=O)OC JMZOMFYRADAWOG-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000004983 pleiotropic effect Effects 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229930009674 sesquiterpene lactone Natural products 0.000 description 1
- 150000002107 sesquiterpene lactone derivatives Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229930182493 triterpene saponin Natural products 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Dispersion Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域Technical field
本发明涉及一种中药复合制剂提取物及制备方法,属于中医药技术领域。The invention relates to a traditional Chinese medicine compound preparation extract and a preparation method, and belongs to the technical field of traditional Chinese medicine.
背景技术Background technique
土茯苓,为百合科植物光叶菝葜Smilax glabra Roxb.的干燥根茎,其为多年生常绿攀缘状灌木,多生于山坡或林下。分布于中国甘肃(南部)和长江流域以南各省区,直到台湾、海南岛和云南。越南、泰国和印度也有分布。主要用于治疗梅毒和皮肤病等。现代药理研究表明土获荃具有广泛的生物活性,主要活性成分有黄酮类、萜类、有机酸类、甾醇类、皂昔类等,具有解毒利湿、祛风止痛、抗肿瘤、抗氧化、免疫抑制等药理作用,有良好的药用价值。此外,土获苓因其丰富的营养成分、毒副作用小、经济价值高等特点,被广泛应用于疾病防治、食品、养殖、护肤品等多个领域,具有良好的应用前景。Smilax glabra Roxb. is the dry rhizome of the Liliaceae plant Smilax glabra Roxb. It is a perennial evergreen climbing shrub that mostly grows on hillsides or understory. Distributed in China's Gansu (southern) and provinces and regions south of the Yangtze River Basin, to Taiwan, Hainan Island and Yunnan. It is also distributed in Vietnam, Thailand and India. Mainly used to treat syphilis and skin diseases. Modern pharmacological research shows that Tuhuoquan has a wide range of biological activities. The main active ingredients are flavonoids, terpenes, organic acids, sterols, saponins, etc. It has pharmacological effects such as immunosuppression and has good medicinal value. In addition, due to its rich nutritional content, low toxic and side effects, and high economic value, Tuhuoling is widely used in many fields such as disease prevention and treatment, food, breeding, and skin care products, and has good application prospects.
蒲公英,为菊科植物蒲公英Taraxacum mongolicum Hand.-Mazz.、碱地蒲公英Taraxacum borealisinense Kitam.或同属数种植物的干燥全草。别名蒲公草、金替草、婆婆丁等,中国全国大部分地区均可见,广泛生于中、低海拔地区的山坡草地、路边、田野、河滩等处。是中国常见的野生蔬菜和中草药。具清热解毒、消肿散结、利尿通淋、美容等功效,主治痈疽疗疮、乳痈等。现代药理研究证实,本品具有利胆保肝、抗菌消炎(风湿性关节炎、口腔炎、牙周炎、妇科炎症等)、利尿、抗氧自由基、抗癌及增强机体免疫功能,临床应用范围不断扩大。此外,蒲公英还含有葡萄糖、维生素、胡萝卜素及丰富的微量元素等多种健康保健营养活性成分,因此具有十分重要的营养价值,卫生部已将其列入药食两用之品。Dandelion is the dried whole grass of Taraxacum mongolicum Hand.-Mazz., Taraxacum borealisinense Kitam., or several species of the same genus. Also known as dandelion grass, golden grass, mother-in-law grass, etc., it can be found in most parts of China. It is widely grown in hillside grasslands, roadsides, fields, river beaches, etc. in medium and low altitude areas. It is a common wild vegetable and Chinese herbal medicine in China. It has the functions of clearing away heat and detoxifying, reducing swelling and dissipating knots, diuresis, treating stranguria, and beautifying. It is mainly used to treat carbuncle, sores, and mastitis. Modern pharmacological research has confirmed that this product has choleretic, hepatoprotective, antibacterial and anti-inflammatory properties (rheumatoid arthritis, stomatitis, periodontitis, gynecological inflammation, etc.), diuresis, antioxidant free radicals, anti-cancer and enhances the body's immune function. It has clinical applications. The scope continues to expand. In addition, dandelion also contains a variety of health-care nutritional active ingredients such as glucose, vitamins, carotene and rich trace elements. Therefore, it has very important nutritional value. The Ministry of Health has listed it as a medicinal and food product.
金银花,正名为忍冬(学名:Lonicera japonica Thunb.为忍冬科植物忍冬的干燥花蕾或带初开的花。属多年生半常绿缠绕及匍匐茎的灌木,多野生于较湿润的地带。中国各省均有分布,主要集中在山东、陕西、河南、河北、湖北、江西、广东等地。具有清热解毒、凉血化淤之功效,主治外感风热、瘟病初起、疮疡疔毒、红肿热痛、便脓血”等。金银花含有多种人体必须的微量元素和化学成分,同时含有多种对人体有利的活性酶物质,具有抗衰老,防癌变,轻身健体的良好功效。被确定为药食兼用品种。蒲公英与金银花,同是消痈化疡之物,金银花得蒲公英而其功更大。Honeysuckle, the correct name is Lonicera japonica Thunb. It is the dried flower bud or newly bloomed flower of Lonicera japonica. It is a perennial semi-evergreen twining and stolid shrub that mostly grows wild in relatively humid areas. All provinces in China are Distributed, mainly in Shandong, Shaanxi, Henan, Hebei, Hubei, Jiangxi, Guangdong and other places. It has the effects of clearing away heat and detoxification, cooling blood and removing blood stasis. It is mainly used to treat exogenous wind-heat, the onset of plague, sores, boils, redness, swelling and heat pain. , fecal pus and blood", etc. Honeysuckle contains a variety of trace elements and chemical components necessary for the human body. It also contains a variety of active enzyme substances that are beneficial to the human body. It has good effects of anti-aging, preventing cancer, and being light-weight and healthy. It is determined to be A variety that can be used both as medicine and food. Dandelion and honeysuckle are both used to eliminate carbuncles and ulcers. Honeysuckle has greater effects than dandelion.
黄芩(Scutellaria baicalensis Georgi.),别名山茶根、土金茶根,是唇形科黄芩属多年生草本植物,野生于山顶、山坡、林缘、路旁等向阳较干燥的地方,主要分布在中国、俄罗斯、蒙古、朝鲜和日本;我国的黑龙江、辽宁、内蒙古、河北、河南、甘肃、山西、山东、四川等地也有广泛种植。具有清热燥湿,泻火解毒,止血,安胎功效,主法湿热痞满,泻痢,黄疸,肺热咳嗽,高热烦渴,血热吐衄,痈肿疮毒,胎动不安等。黄芩根茎为清凉性解热消炎药,外用有抗生作用,茎秆可提制芳香油。现代药理研究表明,黄芩含有多种活性成分,包括黄酮、黄酮昔类、多糖类、挥发油类和微量元素等,其中最主要的是黄酮及黄酮昔类化合物。具有抗炎、抗菌、抗肿瘤、抗氧化、抗衰老、降血糖及保护肝脏、神经和心脏等作用。黄芪是可以用作茶饮的植物,黄芪根茎在中国河北山区有泡茶饮用习惯,称黄芩茶,属于别样茶。黄芩茎叶泡出的茶色泽金黄,口感清新,而且有去火等保健作用。Scutellaria baicalensis Georgi., also known as camellia root and earth gold tea root, is a perennial herbaceous plant of the genus Scutellaria of the family Lamiaceae. It grows wild in sunny and dry places such as mountain tops, hillsides, forest edges, and roadsides. It is mainly distributed in China, Russia, Mongolia, North Korea and Japan; my country's Heilongjiang, Liaoning, Inner Mongolia, Hebei, Henan, Gansu, Shanxi, Shandong, Sichuan and other places are also widely planted. It has the effects of clearing away heat and drying dampness, purging fire and detoxifying, stopping bleeding, and anti-fetus. It is mainly used to treat damp-heat fullness, diarrhea, jaundice, lung-heat cough, high fever and polydipsia, blood-heat vomiting epistaxis, carbuncle and sore, uneasy fetal movement, etc. The rhizome of Scutellaria baicalensis is a cooling, antipyretic and anti-inflammatory drug with antibiotic effects for external use. The stems can be used to extract aromatic oil. Modern pharmacological research shows that Scutellaria baicalensis contains a variety of active ingredients, including flavones, flavonoids, polysaccharides, volatile oils and trace elements, the most important of which are flavones and flavonoids. It has anti-inflammatory, antibacterial, anti-tumor, antioxidant, anti-aging, hypoglycemic and protective effects on the liver, nerves and heart. Astragalus is a plant that can be used as tea. The rhizome of Astragalus is used to make tea and drink in the mountainous areas of Hebei, China. It is called Scutellaria baicalensis tea, which is a different kind of tea. The tea brewed from the stems and leaves of Scutellaria baicalensis is golden in color, fresh in taste, and has health-care effects such as removing internal heat.
以上四种中药均为药食同源清热解素类药。清热解毒类中草药在抗菌、消炎和防腐中起着不可忽视的作用,中草药植物不仅可内服亦可外敷,在生活与生产中具有重要应用前景。历代医药工作者在长期医疗实践中总结经验,选择性地将两味或多味中药结合配伍,药物配伍的研究是研究方剂配伍规律的新方法、新方向、新途径。中药配伍可以起到事半功倍的作用。这是由于中药成分及各成分间相互作用的必然结果。药物配合运用较单味药更具优势,如有效物质溶出率提高,可能产生新的化学分子,使得中药复合制剂具有多靶点性、多效性等优点。The above four traditional Chinese medicines are all heat-clearing and resolving hormones with the same origin as medicine and food. Chinese herbal medicines that clear away heat and detoxify play an important role in antibacterial, anti-inflammatory and antiseptic properties. Chinese herbal medicines can be taken not only internally but also externally, and have important application prospects in life and production. Medical workers of past generations have summed up their experience in long-term medical practice and selectively combined two or more traditional Chinese medicines. The study of drug compatibility is a new method, new direction, and new way to study the rules of prescription compatibility. The compatibility of traditional Chinese medicine can achieve twice the result with half the effort. This is the inevitable result of the components of traditional Chinese medicine and the interaction between each component. The combined use of drugs has more advantages than single drugs. If the dissolution rate of effective substances is increased, new chemical molecules may be produced, making the traditional Chinese medicine compound preparations have the advantages of multi-targeting and pleiotropic effects.
药食同源植物复合剂的研究在生活生产中占有重要地位,尤其是中草药植物提取物的防腐保质作用,在防腐保质的过程中起到,中草药植物也能起到健康保健作用。The research on medicinal and edible plant compound agents plays an important role in life and production, especially the antiseptic and quality-preserving effects of Chinese herbal plant extracts, which play a role in the antiseptic and quality-preserving process. Chinese herbal medicine plants can also play a health care role.
发明内容Contents of the invention
为解决现有技术的不足,本发明提供了一种中药复合制剂提取物及制备方法,采用的技术方案如下:In order to solve the deficiencies of the existing technology, the present invention provides a traditional Chinese medicine compound preparation extract and a preparation method. The technical solutions adopted are as follows:
本发明的目的在于提供一种中药复合制剂、提取物及制备方法,该方法是一种中药提取物,提取自以下四种中药的组合以及任意含土茯苓的三种中药组合:The object of the present invention is to provide a traditional Chinese medicine compound preparation, extract and preparation method. The method is a traditional Chinese medicine extract, which is extracted from a combination of the following four traditional Chinese medicines and any three traditional Chinese medicine combinations containing Smilax smilax.
1)土茯苓;1) Smilax poria;
2)蒲公英;2) Dandelion;
3)金银花;3) Honeysuckle;
4)黄芩:4) Scutellaria baicalensis:
所述中药土茯苓为植物干燥后的根茎;蒲公英为植物干燥的全草;金银花为忍冬植物干燥花蕾或带初开的花(连枝叶);黄芩为植物干燥的根。The traditional Chinese medicine Smilax poria is the dried rhizome of the plant; dandelion is the dried whole plant; honeysuckle is the dried flower bud or newly opened flower (with branches and leaves) of the honeysuckle plant; and skullcap is the dried root of the plant.
所述提取物的制备方法是将权利要求1所述三种中药组合或四种中药组合物经加热、煎煮制成水煎剂,再利用63%的乙醇、76%的乙醇、81%的乙醇过夜沉淀处理,获得醇溶物和醇沉物,分别进行浓缩或干燥,获得粗提取物,粗提物再分离纯化,获得中药提取物。The preparation method of the extract is to heat and boil the three Chinese medicine combinations or four Chinese medicine compositions described in claim 1 to form a water decoction, and then use 63% ethanol, 76% ethanol, 81% After an overnight ethanol precipitation treatment, the alcohol soluble product and the alcohol precipitate are obtained, which are concentrated or dried respectively to obtain a crude extract. The crude extract is then separated and purified to obtain a Chinese medicine extract.
所述方法步骤如下:The method steps are as follows:
1)对任意含土茯苓的三种中药或四种中药组合物进行预处理,获得预处理中药;1) Pre-process any three Chinese medicines or four Chinese medicine compositions containing Smilax poria to obtain the pretreated Chinese medicine;
2)将步骤1)所得的预处理中药熬制成水煎剂或粉或药包;2) Boil the pretreated Chinese medicine obtained in step 1) into a water decoction, powder or medicinal packet;
3)将步骤2)所得水煎剂用乙醇进行过液沉淀处理,获得醇溶物和醇沉物;3) The water decoction obtained in step 2) is subjected to liquid precipitation treatment with ethanol to obtain alcohol soluble products and alcohol precipitates;
4)将步骤3)所得醇溶物与醇沉物分别进行浓缩或干燥,获得中药粗提物;4) Concentrate or dry the alcohol-soluble product and alcohol precipitate obtained in step 3) respectively to obtain a crude extract of traditional Chinese medicine;
5)再利用硅胶快速色谱技术、高效液相色谱技术对步骤4)所得粗提取物进行分离纯化,获得中药提取物。5) Then use silica gel fast chromatography technology and high performance liquid chromatography technology to separate and purify the crude extract obtained in step 4) to obtain the traditional Chinese medicine extract.
步骤1)所述中药是土茯苓、蒲公英、金银花、黄芩四种以及任意含土茯苓的三种中药组合制剂、悬浮剂、粉或药包;所述中药组合物是土茯苓、蒲公英、金银花、黄芩四种1:1:1:1组合以及任意含土茯苓的三种中药组合1:1:1。Step 1) The traditional Chinese medicines are Smilax poria, dandelion, honeysuckle and skullcap, as well as any three traditional Chinese medicine combination preparations, suspensions, powders or medicine packets containing Smilax. The Chinese medicine composition is Smilax, dandelion, honeysuckle, Four 1:1:1:1 combinations of Scutellaria baicalensis and any three Chinese medicine combinations containing Smilax Poria cocos 1:1:1.
步骤1)所述预处理,是用水浸泡中药组合物,浸泡条件为室温浸泡2小时,水的添加量为草药总药量的20倍。The pretreatment described in step 1) is to soak the traditional Chinese medicine composition in water. The soaking condition is room temperature for 2 hours. The amount of water added is 20 times the total dosage of the herbal medicine.
步骤2)所述制成水煎剂,是将预处理中药或中药组合物,先煮沸,之后小火熬制30分钟,收集熬制液,再加入10倍水,先煮沸再小火熬制30分种,收集熬制液,合并两次药液,静置过夜,次日先收集上清液,沉淀物用3000rpm离心20分钟收集上清液,全部上清液在100℃煮沸条件下浓缩至400mL,最后100℃水浴,浓缩至100mL水煎剂,备用。To make a water decoction as described in step 2), boil the pretreated Chinese medicine or Chinese medicine composition first, and then simmer it over low heat for 30 minutes. Collect the boiling liquid, then add 10 times of water, boil it first and then simmer over low heat. After 30 minutes, collect the boiling liquid, combine the two liquids, let it stand overnight, collect the supernatant first the next day, centrifuge the precipitate at 3000 rpm for 20 minutes to collect the supernatant, and concentrate the entire supernatant under boiling conditions at 100°C. to 400mL, and finally in a 100°C water bath, concentrate to 100mL water decoction and set aside.
步骤3)所述乙醇过夜沉淀处理,是向120mL水煎剂浓缩液分成三份,每份40mL,中加入80mL95%无水乙醇,使之成为63%乙醇,是向40mL水煎剂浓缩液中160mL95%无水乙醇,使之成为76%乙醇,是向100mL水煎剂浓缩液中加入240mL95%无水乙醇,使之成为81%乙醇,室温过夜24小时,将获得的三份醇溶物和醇沉物合并,形成醇溶物混合物和醇沉物混合物。The ethanol overnight precipitation treatment in step 3) is to divide 120 mL of water decoction concentrate into three parts, each part is 40 mL, and add 80 mL of 95% absolute ethanol to make it 63% ethanol, and add 40 mL of water decoction concentrate to To make 160 mL of 95% absolute ethanol into 76% ethanol, add 240 mL of 95% absolute ethanol to 100 mL of water decoction concentrate to make it into 81% ethanol. Leave it overnight at room temperature for 24 hours. Add three portions of the obtained alcohol solution and The alcohol precipitates combine to form an alcohol soluble mixture and an alcohol precipitate mixture.
步骤4)所述中药醇溶物混合物和醇沉物混合物分别经100℃水浴浓缩至膏状,减压过滤形成干燥粉末,于80℃干燥箱中干燥,备用。Step 4) The Chinese medicine alcohol-soluble mixture and the alcohol-precipitated mixture were concentrated in a 100°C water bath to a paste, filtered under reduced pressure to form dry powder, dried in a drying oven at 80°C, and set aside.
本发明所述方法,适用于中药复合的制剂、提取中药、中药水煎剂或粗提取物中的活性成分。The method of the present invention is suitable for compound preparations of traditional Chinese medicines, extracting active ingredients from traditional Chinese medicines, Chinese medicine decoctions or crude extracts.
本发明有益效果:Beneficial effects of the present invention:
1.利用本发明提供的中药组合物、提取物及制备方法熬制的汤剂更符合中药的性、味、归、经的要求,更好的诠释中药方剂配伍君、臣、佐、使的用法,通过用法发挥药物之间的相生相克作用。1. The decoction prepared by using the traditional Chinese medicine composition, extract and preparation method provided by the invention is more in line with the requirements of the nature, taste, return and meridians of traditional Chinese medicine, and better interprets the compatibility of traditional Chinese medicine prescriptions with monarch, minister, adjuvant and make. Usage: Use usage to bring out the mutually reinforcing and mutually reinforcing effects between drugs.
2.利用本发明提供的中药提取物的制备方法,能够在一定程度上实现对中药提取物多种活性化学成分控制,获得含有多种化学成分的中药提取物,更好的体现中药汤剂有效成分的药效与药性。2. Utilizing the preparation method of traditional Chinese medicine extracts provided by the present invention, it is possible to control multiple active chemical components of traditional Chinese medicine extracts to a certain extent, obtain Chinese medicine extracts containing multiple chemical components, and better reflect the effectiveness of traditional Chinese medicine decoctions. The efficacy and medicinal properties of the ingredients.
3.本发明所提供的中药提取物,具有抗菌、消炎、防腐保质的作用。经实验验证,本发明所制备的中药提取物在体外具有抗菌作用和提高机体免疫力的作用。3. The traditional Chinese medicine extract provided by the present invention has antibacterial, anti-inflammatory, antiseptic and quality-preserving effects. It has been experimentally verified that the Chinese medicine extract prepared in the present invention has antibacterial effects and the effect of improving the body's immunity in vitro.
具体实施方式Detailed ways
下面结合具体实施例对本发明做进一步说明,但本发明不受实施例的限制。经过对配伍比例进行优化后,根据得到的具有较佳效果的配伍比例,列举如下配伍组合作进一步说明:The present invention will be further described below with reference to specific examples, but the present invention is not limited by the examples. After optimizing the compatibility ratio, based on the obtained compatibility ratio with better effect, the following compatibility combinations are listed for further explanation:
实施例1:土茯苓、蒲公英、金银花、黄芩组合物的提取物的制备Example 1: Preparation of extracts of Smilax poria, dandelion, honeysuckle and skullcap compositions
向土茯苓30g、蒲公英30g、金银花30g、黄芩30g四种全草中加中药总药量(120g)的20倍水,于室温下浸泡2小时,得到预处理中药。将所得的预处理中药在100℃下,熬制30小时,利用4层纱布过滤(常压过滤)熬制液,再加入10倍水,熬制30分钟,利用4层纱布过滤熬制液去药渣。两次药液合并,静置过夜。次日,取上清液,沉淀离心过滤(3000rpm,20分钟),合并所有上清液,煮沸浓缩至400mL,然后100℃水浴锅将上清液浓缩至120mL水煎剂,分成三份,每份40mL,分别加入80mL95%无水乙醇,使之成为63%乙醇;加入160mL95%无水乙醇,使之成为76%乙醇;加入240mL95%无水乙醇,使之成为81%乙醇,室温过夜24小时,将获得的三份醇溶物和醇沉物合并,形成醇溶物混合物和醇沉物混合物。醇溶物混合物和醇沉物混合物分别经100℃水浴浓缩至膏状,减压过滤形成干燥粉末,于80℃干燥箱中干燥,备用。Add 20 times of the total dosage of traditional Chinese medicine (120g) to four whole herbs: 30g of Smilax, 30g of Dandelion, 30g of Honeysuckle, and 30g of Scutellaria baicalensis, and soak them at room temperature for 2 hours to obtain the pretreated traditional Chinese medicine. Boil the obtained pretreated Chinese medicine for 30 hours at 100°C, filter the boiled liquid with 4 layers of gauze (normal pressure filtration), then add 10 times of water, simmer for 30 minutes, and filter the boiled liquid with 4 layers of gauze. Drug residue. Combine the two solutions and let sit overnight. The next day, take the supernatant, centrifuge the sediment (3000 rpm, 20 minutes), combine all the supernatants, boil and concentrate to 400 mL, then concentrate the supernatant in a 100°C water bath to 120 mL of water decoction, divide it into three parts, each 40 mL portion, add 80 mL 95% absolute ethanol to make it 63% ethanol; add 160 mL 95% absolute ethanol to make it 76% ethanol; add 240 mL 95% absolute ethanol to make it 81% ethanol, and leave it at room temperature overnight for 24 hours. , combine the three alcohol solubles and alcohol precipitates obtained to form an alcohol soluble product mixture and an alcohol precipitate mixture. The alcohol-soluble product mixture and the alcohol-precipitated product mixture were concentrated in a 100°C water bath to a paste, filtered under reduced pressure to form dry powder, dried in a drying oven at 80°C, and set aside.
实施例2:土茯苓、蒲公英、金银花组合物的提取物的制备Example 2: Preparation of extracts of Smilax poria, dandelion and honeysuckle compositions
向土茯苓30g、蒲公英30g、金银花30g三种全草中加中药总药量(90g)的20倍水,于室温下浸泡2小时,得到预处理中药。将所得的预处理中药在100℃下,熬制30小时,利用4层纱布过滤(常压过滤)熬制液,再加入10倍水,熬制30分钟,利用4层纱布过滤熬制液去药渣。两次药液合并,静置过夜。次日,取上清液,沉淀离心过滤(3000rpm,20分钟),合并所有上清液,煮沸浓缩至400mL,然后100℃水浴锅将上清液浓缩至120mL水煎剂,分成三份,每份40mL,分别加入80mL95%无水乙醇,使之成为63%乙醇;加入160mL95%无水乙醇,使之成为76%乙醇;加入240mL95%无水乙醇,使之成为81%乙醇,室温过夜24小时,将获得的三份醇溶物和醇沉物合并,形成醇溶物混合物和醇沉物混合物。醇溶物混合物和醇沉物混合物分别经100℃水浴浓缩至膏状,减压过滤形成干燥粉末,于80℃干燥箱中干燥,备用。Add 20 times of the total dosage of traditional Chinese medicine (90g) to three whole herbs: 30g of Smilax poria, 30g of dandelion, and 30g of honeysuckle, and soak them at room temperature for 2 hours to obtain the pretreated traditional Chinese medicine. Boil the obtained pretreated Chinese medicine for 30 hours at 100°C, filter the boiled liquid with 4 layers of gauze (normal pressure filtration), then add 10 times of water, simmer for 30 minutes, and filter the boiled liquid with 4 layers of gauze. Drug residue. Combine the two solutions and let sit overnight. The next day, take the supernatant, centrifuge the sediment (3000 rpm, 20 minutes), combine all the supernatants, boil and concentrate to 400 mL, then concentrate the supernatant in a 100°C water bath to 120 mL of water decoction, divide it into three parts, each 40 mL portion, add 80 mL 95% absolute ethanol to make it 63% ethanol; add 160 mL 95% absolute ethanol to make it 76% ethanol; add 240 mL 95% absolute ethanol to make it 81% ethanol, and leave it at room temperature overnight for 24 hours. , combine the three alcohol solubles and alcohol precipitates obtained to form an alcohol soluble product mixture and an alcohol precipitate mixture. The alcohol-soluble product mixture and the alcohol-precipitated product mixture were concentrated in a 100°C water bath to a paste, filtered under reduced pressure to form dry powder, dried in a drying oven at 80°C, and set aside.
实施例3:实施例四种和含土茯苓的三种中药组合粗提取物提各组分分析结果Example 3: Analysis results of each component of the crude extracts of the four embodiments and three Chinese medicine combinations containing Smilax poria.
供试液中总黄酮类含量测定实施过程:The implementation process of determining the total flavonoids content in the test solution:
精密称取中药醇溶物干燥粉末2g完全溶于20ml水,由上至下倒入聚酰胺树脂柱中,95%乙醇重复洗脱5次,洗脱液即为样品中的总黄酮。过滤洗脱液,浓缩,定容至25ml。移取供试液1ml,按以下标准芦丁曲线绘制操作,测定吸光度值。Precisely weigh 2g of the dry powder of alcohol-soluble Chinese medicine and completely dissolve it in 20ml of water. Pour it into the polyamide resin column from top to bottom. Repeat elution with 95% ethanol 5 times. The eluent is the total flavonoids in the sample. Filter the eluate, concentrate, and adjust the volume to 25 ml. Pipette 1ml of the test solution, draw the following standard rutin curve, and measure the absorbance value.
精密称定芦丁对照品2.5mg,,置25ml量瓶中,加甲醇溶解,摇匀,即得浓度为0.1mg/ml的标准品溶液。分别取芦丁标准液0,0.5,1,1.5,2,2.5,3mL至10mL容量瓶,加入4mL1%A lCl3溶液,95%乙醇定溶至10mL,摇匀,静置15min。于405nm处测定吸光度值,以标准品浓度为横坐标,绘制标准曲线图,计算得回归方程。Accurately weigh 2.5 mg of rutin reference substance, place it in a 25 ml volumetric flask, add methanol to dissolve, and shake well to obtain a standard solution with a concentration of 0.1 mg/ml. Take 0, 0.5, 1, 1.5, 2, 2.5, 3 mL of rutin standard solution into a 10 mL volumetric flask respectively, add 4 mL of 1% AlCl3 solution, and dissolve 95% ethanol to 10 mL, shake well, and let stand for 15 minutes. Measure the absorbance value at 405nm, draw the standard curve with the concentration of the standard as the abscissa, and calculate the regression equation.
供试液中总萜类含量测定实施过程:The implementation process of determining the total terpene content in the test solution:
精密称取中药醇溶物干燥粉末2g完全溶于20ml水,由上至下倒入D101大孔树脂柱中,95%乙醇重复洗脱5次,洗脱液即为样品中的总黄酮。过滤洗脱液,浓缩,定容至25ml。密吸取供试液样品0.2mL,按齐墩果酸对照品溶液处理方法处理,测定吸光度。Precisely weigh 2g of the dry powder of alcohol-soluble Chinese medicine and completely dissolve it in 20ml of water. Pour it into the D101 macroporous resin column from top to bottom. Repeat elution with 95% ethanol 5 times. The eluate is the total flavonoids in the sample. Filter the eluate, concentrate, and adjust the volume to 25 ml. Densely absorb 0.2 mL of the test solution sample, process it according to the treatment method of oleanolic acid reference solution, and measure the absorbance.
齐墩果酸标准曲线:准确称取齐墩果酸5mg,用乙醇定容于25ml容量瓶中,配成浓度为0.2mg/ml齐墩果酸标准溶液。精密吸取0.1,0.2,0.3,0.4,0.5,0.6mL的齐墩果酸标准溶液置于刻度试管中,加热挥去溶剂,加入新配制的5%香草醛-冰醋酸溶液0.4mL及高氯酸1.6mL于60℃恒温水浴20min后冷却至室温,加入乙酸乙酯定容至5ml,摇匀,于550nm处测定吸光度,以对照品溶液溶度为横坐标,吸光度为纵坐标绘制标准曲线,计算得回归方程。Oleanolic acid standard curve: Accurately weigh 5 mg of oleanolic acid, dilute it with ethanol into a 25ml volumetric flask, and prepare an oleanolic acid standard solution with a concentration of 0.2mg/ml. Precisely pipette 0.1, 0.2, 0.3, 0.4, 0.5, 0.6mL of oleanolic acid standard solution into a graduated test tube, heat to evaporate the solvent, and add 0.4mL of newly prepared 5% vanillin-glacial acetic acid solution and perchloric acid Place 1.6 mL in a constant temperature water bath at 60°C for 20 minutes and then cool to room temperature. Add ethyl acetate to adjust the volume to 5 ml. Shake well. Measure the absorbance at 550 nm. Draw a standard curve with the solubility of the reference solution as the abscissa and the absorbance as the ordinate. Calculate Get the regression equation.
表1实施例3粗提取物各组分分析结果Table 1 Analysis results of components of the crude extract of Example 3
由表1可以知道:黄芩作为根茎类药材,含糖量比较高,由于其主要含有黄酮类化合物,因些,四种中药组合和三种中药组的的黄酮类含量增多大于总萜类含量的增多。黄酮类化合物是抗菌作用的主要化学成分之一。土茯苓是主要成分除了苷元或皂苷类化合物,是三萜类化合物,也含有黄酮类、酚类、有机酸类等物质。蒲公英的化学成分主要有黄酮类、萜类、芬酸类、植物甾醇、倍半萜内脂和香豆素类等。金银花主要包括挥发油类、黄酮类、有机酸类、环烯醚萜苷类、三萜皂苷类及其他类成分。这些药食同源的药物在总黄酮与总萜化合物上起到叠加的作用。具有较强的抗菌消炎作用。It can be seen from Table 1 that Scutellaria baicalensis, as a rhizome medicinal material, has a relatively high sugar content because it mainly contains flavonoids. Therefore, the increase in the flavonoid content of the four Chinese medicine combinations and the three Chinese medicine groups is greater than the total terpenoid content. increase. Flavonoids are one of the main chemical components responsible for antibacterial effects. The main component of Smilax Poria is not only aglycones or saponins, but also triterpenoids. It also contains flavonoids, phenols, organic acids and other substances. The chemical components of dandelion mainly include flavonoids, terpenes, fenacs, phytosterols, sesquiterpene lactones and coumarins. Honeysuckle mainly includes volatile oils, flavonoids, organic acids, iridoid glycosides, triterpene saponins and other components. These drugs with the same origin as medicine and food play a superimposed effect on total flavonoids and total terpenes. It has strong antibacterial and anti-inflammatory effects.
实施例4:实施例四种中药组合粗提取物抑菌效果Example 4: Antibacterial effect of crude extracts of four traditional Chinese medicine combinations
采取了以下实验进行验证:The following experiments were taken for verification:
将30g/mL的中药不同组合物,用无菌水稀释成含生药5%,10%,15%,20%,30%等不同浓度的溶液。将活化好的各供试菌种用无菌水分别制成含菌数约1*108CFU/ml的菌悬液。采用无菌滤纸片法,孔器制备纸片直径为6mm,MH固体培养基,每片点药量为5微升,每种浓度重复3次,观察滤纸周围有无抑菌圈。Different compositions of traditional Chinese medicine at 30g/mL were diluted with sterile water into solutions containing different concentrations of crude drugs such as 5%, 10%, 15%, 20%, and 30%. Use sterile water to prepare each activated test strain into a bacterial suspension containing approximately 1*10 8 CFU/ml. Use the sterile filter paper disk method. The diameter of the paper disk prepared by the hole device is 6 mm, and the MH solid medium is used. The dosage of each disk is 5 microliters. Each concentration is repeated three times. Observe whether there is an inhibitory zone around the filter paper.
由表2可知,土茯苓、蒲公英、金银花、黄芩组合水煎液对大肠杆菌、肺炎链球菌、金黄色葡萄球菌、化脓性链球菌、枯草芽孢杆菌有较强的抑制作用,且浓度愈高,抑菌活性愈强,尤对大肠杆菌、金黄色葡萄球菌、枯草芽孢杆菌的抑制作用抑制作用较弱强。It can be seen from Table 2 that the decoction of Smilax poria, dandelion, honeysuckle, and skullcap has a strong inhibitory effect on Escherichia coli, Streptococcus pneumoniae, Staphylococcus aureus, Streptococcus pyogenes, and Bacillus subtilis, and the higher the concentration, the The stronger the antibacterial activity, the weaker the inhibitory effect on Escherichia coli, Staphylococcus aureus, and Bacillus subtilis.
表2不同浓度四种中药组合物水煎液的抑菌效果(以抑菌圈直径表示,mm)Table 2 Antibacterial effects of four kinds of traditional Chinese medicine composition water decoctions at different concentrations (expressed by the diameter of the inhibitory zone, mm)
-无抑菌圈-No inhibition zone
实施例5:四种中药组合提取物对急性肝损伤小鼠保护作用效果Example 5: Protective effect of four traditional Chinese medicine combination extracts on mice with acute liver injury
采取了以下实验进行验证:模型组给予0.9%生理盐水(10ml/kg)灌胃,阳性组给予联苯双酯滴丸混悬液(150mg/kg)灌胃给药,四种中药组合高、中、低剂量组分别给予对应剂量的四种中药组合溶液(生药/鼠重:2g/kg、1g/kg、0.5g/kg)灌胃。给药10天,末次给药后2h,再次称重,注射部位为右侧腹腔,除空白组外,其余各组均腹腔注射10%四氯化碳花生油混合液(10ml/kg),成功建立急性肝损伤模型造模。The following experiments were conducted for verification: the model group was given 0.9% normal saline (10ml/kg) by gavage, and the positive group was given bifendate dropping pill suspension (150mg/kg) by gavage. The combination of four traditional Chinese medicines had high The medium and low dose groups were given corresponding doses of four traditional Chinese medicine combination solutions (crude medicine/mouse weight: 2g/kg, 1g/kg, 0.5g/kg) by gavage. After 10 days of administration, the subjects were weighed again 2 hours after the last administration. The injection site was the right abdominal cavity. Except for the blank group, all other groups were intraperitoneally injected with 10% carbon tetrachloride peanut oil mixture (10ml/kg) to successfully establish Acute liver injury model modeling.
表3实施例5中不同中药组合物提取物对急性肝损伤小鼠保护作用效果Table 3 Example 5: The protective effects of different traditional Chinese medicine composition extracts on mice with acute liver injury
由表3可知,土茯苓、蒲公英、金银花、黄芩组合水煎液高、中剂量组可以降低肝脏指数,夏枯草高、中、低剂量组降低脾脏脂数和胸腺系数。中药对机体损伤小鼠具有解毒作用,机体具有一定抵抗力,体重无明显下降。It can be seen from Table 3 that the high- and medium-dose decoction groups of Smilax, dandelion, honeysuckle, and skullcap can reduce liver index, and the high-, medium-, and low-dose groups of Prunella vulgaris can reduce spleen lipid count and thymus coefficient. Traditional Chinese medicine has a detoxifying effect on injured mice, and the body has a certain degree of resistance without significant weight loss.
虽然本发明已以较佳的实施例公开如上,但其并非用以限定本发明,任何熟悉此技术的人,在不脱离本发明的精神和范围内,都可以做各种改动和修饰,因此本发明的保护范围应该以权利要求书所界定的为准。Although the present invention has been disclosed above in terms of preferred embodiments, they are not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, The protection scope of the present invention should be defined by the claims.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311735336.8A CN117679479A (en) | 2023-12-18 | 2023-12-18 | A kind of traditional Chinese medicine compound preparation extract and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311735336.8A CN117679479A (en) | 2023-12-18 | 2023-12-18 | A kind of traditional Chinese medicine compound preparation extract and preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117679479A true CN117679479A (en) | 2024-03-12 |
Family
ID=90133336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311735336.8A Pending CN117679479A (en) | 2023-12-18 | 2023-12-18 | A kind of traditional Chinese medicine compound preparation extract and preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117679479A (en) |
-
2023
- 2023-12-18 CN CN202311735336.8A patent/CN117679479A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20110318438A1 (en) | Pharmacologically effective composition of herbs for treatment on symptoms of influenza and colds | |
CN101411782B (en) | Pharmaceutical composition for treating acute pharyngitis and preparation method thereof | |
Gour | Boerhaavia diffusa Linn plant: a review–one plant with many therapeutic uses | |
CN104208393B (en) | It is a kind of to be used to prevent Chinese medicine composition of infectious bronchitis of chicken and preparation method thereof | |
CN111870568A (en) | Anti-allergy itching-relieving plant composition and preparation method and application thereof | |
KR101566822B1 (en) | A cosmetic composition for improving atopic symptoms containing a herbal medicine extract | |
CN104161977B (en) | It is a kind of to be used to prevent and treat Chinese medicine composition of infectious coryza of chicken and preparation method thereof | |
CN103520552B (en) | Traditional Chinese medicine composition for treating acute conjunctivitis and preparation method thereof | |
CN108324749B (en) | Traditional Chinese medicine composition for treating acne and preparation method and application thereof | |
CN107890486B (en) | Traditional Chinese medicine external anti-inflammation preparation and preparation method and application thereof | |
CN117679479A (en) | A kind of traditional Chinese medicine compound preparation extract and preparation method | |
CN106039148B (en) | Liver-protecting Mongolian medicine | |
CN104383068A (en) | High-efficiency, antiviral and bacteriostatic traditional Chinese veterinary medicine | |
CN108079067A (en) | A kind of nursing washing lotion and preparation method thereof | |
JPH01172340A (en) | Preventive and remedy for staphylococcal disease of chicken | |
CN107233486A (en) | It is a kind of to treat old salt lemon composition of pharyngitis and preparation method thereof | |
CN116440210B (en) | Traditional Chinese medicine composition for treating diabetic foot and application thereof | |
CN105561098A (en) | Medicine for treating erosive beriberi | |
Konczak et al. | Health Attributes, Antioxidant Properties and Phytochemical Composition of Traditional Medicinal Plants from Eastern Anatolia | |
CN104383191B (en) | The Chinese medicine composition and preparation method of a kind of clearing liver and reducing blood pressure | |
CN109568496B (en) | A kind of detection method of traditional Chinese medicine composition for treating diabetes | |
CN108404007A (en) | A kind of feed addictive and preparation method thereof of prevention necrotic enteritis | |
CN115531489A (en) | Scar-removing traditional Chinese medicine composition and preparation method thereof | |
CN105663429A (en) | Medicine for treating vesicular beriberi | |
CN105311335A (en) | Traditional Chinese medicine composition for assisting tumor chemoradiotherapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |